Castellano | Euskara | Français | English

Use the search tool!

The Bulletin

About us

Conflicts of interest

Search

Subscribe

Home

Recent issues

Vol 31 No 4

• Glucagon-like peptide 1 receptor agonists (GLP1a) and the problem of obesity

Vol 31 No 3

• Use of fluid therapy in clinical practice

Vol 31 No 2

• Safe drug use in patients with cirrhosis

Vol 31 No 1

• Long-acting injectable antipsychotics in schizophrenia

Vol 30 No 4

• Interchage of biosimilar medicines: effective, safe and efficient

Vol 30 No 3

• Topical corticosteroids during childhood

Vol 30 No 2

• Infection risk of targeted synthetic drugs used in immune-mediated inflammatoty diseases

Vol 30 No 1

• An update on pre-hospital management of major trauma

Vol 29 No 4

• Antidepressant safe use, deprescription and switching guideline

Vol 29 No 3 

• Suicidality associated with the use of antidepressants in children and adolescents

Vol 29 No 2 

• Risks and uncertainties about gabapentinoids

Vol 29 No 1 

• What´s left and new in the management of migraine?

Vol 28 No 4 

• Glucose-lowering therapy in patients with type 2 diabetes mellitus and heart failure

Vol 28 No 3 

• Risk of infection associated with biological agents used for autoinmune inflammatory diseases

Vol 28 No 2

• Deprescribing in dementia

Vol 28 No 1 

• Direct oral anticoagulants (DOACs) for new indications

Vol 27 No 4

• Key points for the appropriate use of opioids in chronic non-cancer pain

 Vol 27 No 3

• Medicinal plants: natural but not innocuous (Part 2)

Vol 27 No 2 

• Medicinal plants: natural but not innocuous (Part 1)

Vol 27 No 1 

• Aspects of insulin therapy in Diabetes Mellitus

Vol 26 No 4

• Vitamin D testing and supplementation in adults. Sun and shadows

Vol 26 No 3 

• Mineral supplements: Are they really necessary?

Vol 26 No 1 

• Valproic acid and pregnancy. A problem for reflection

Vol 25 No 4 

• We gotta stop smokin´, stop, stop...Smoking cessation strategies

Vol 25 No 3 

• Sacubitril/Valsartan in heart failure. A critical review of the paradigm-HF trial

Vol 25 No 1 

• Homeopathy: a non-scientific approach to human disease

Vol 24, No 5

• Contribution of bronchodilator combination therapies to COPD

Vol 24, No 4 

• New antidiabetic drugs: what place should they have in therapeutics?

Vol 24, Nº 3 

• The EMPA-REG OUTCOME  trial (empagliflozin). A critical appraisal. The power of truth, the truth of power

Vol 24, No 2 

• Safety considerations for NSAIDs

Vol 24, No 1 

• Uncertainties about new oral anticoagulants in atrial fibrillation. Deficiencies and irregulatities in the authorization process.

   ARCHIVE: 2007- 2020

 

2021	2020	2019	2018	2017
2016	2015	2014	2013	2012
2011	2010	2009	2008	2007

Contact us | Accessibility | Legal notice | Site map